Status:

COMPLETED

Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)

Lead Sponsor:

Hellenic Oncology Research Group

Collaborating Sponsors:

University Hospital of Crete

Conditions:

Non-Small Cell Lung Cancer

Eligibility:

All Genders

18-75 years

Phase:

PHASE3

Brief Summary

This trial will compare the effectiveness of Docetaxel with or without Carboplatin as second line chemotherapy in patients with Non-Small Cell Lung Cancer, who have not been treated previously with Do...

Eligibility Criteria

Inclusion

  • Histologically or cytologically confirmed NSCLC.
  • ECOG Performance Status 0-2.
  • No previous treatment with Docetaxel.
  • Measurable Disease.
  • Brain metastases that have been treated with radiotherapy should be stable and asymptomatic.
  • Adequate liver kidney and bone marrow function.
  • Patients must be able to understand the nature of this study and give written informed consent.

Exclusion

  • Active cardiac disease: unstable angina or onset of angina within last 3 months, myocardial infarction within 6 months, congestive heart failure \> class II, cardiac ventricular arrhythmias requiring anti-arrhythmic therapy.
  • Women who are pregnant or lactating.
  • Unknown HIV, chronic hepatitis B or chronic hepatitis C infections.
  • Serious neurologic or psychiatric disease.
  • Second primary malignancy within the past 5 years, except nonmelanomas skin cancer or in situ carcinoma of the cervix.
  • Active uncontrolled infection.

Key Trial Info

Start Date :

July 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2008

Estimated Enrollment :

135 Patients enrolled

Trial Details

Trial ID

NCT00430651

Start Date

July 1 2004

End Date

May 1 2008

Last Update

January 28 2009

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

University Hospital of Crete

Heraklion, Crete, Greece, 71110

2

University General Hospital of Alexandroupolis, Dep of Medical Oncology

Alexandroupoli, Greece

3

"IASO" General Hospital of Athnes, Dep of Medical Oncology

Athens, Greece

4

"Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine

Athens, Greece